In addition to anti-apoptotic, migratory and invasive activities of the PCP4/PEP19 [13, 16], our results indicated the PCP4/PEP19 enhances aromatase expression in ER- SK-BR-3 human breast cancer cells. Here, ESR1 is linked to breast carcinoma.